San Diego, CA -- (SBWire) -- 12/30/2016 --A deadline is coming up on January 9, 2016 in the lawsuit filed for investors of Diplomat Pharmacy Inc (NYSE:DPLO) over alleged securities laws violations by Diplomat Pharmacy.
Investors who purchased shares of Diplomat Pharmacy Inc (NYSE:DPLO) have certain options and there are strict and short deadlines running. Deadline: January 9, 2016. NYSE:DPLO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Michigan the plaintiff alleges on behalf of certain purchasers of Diplomat Pharmacy Inc (NYSE:DPLO) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the Defendants made false and/or misleading statements and/or failed to disclose that Diplomat Pharmacy Inc lacked adequate internal controls over its financial reporting, that as a result Diplomat Pharmacy Inc could not adequately calculate DIR fees, that the Company's hepatitis C segment was not performing as previously disclosed to investors, that and therefore, Diplomat Pharmacy Inc had overstated its full-year 2016 guidance, and that that, as a result of the foregoing, Defendants' statements about Diplomat Pharmacy Inc's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.
On November 2, 2016, Diplomat Pharmacy Inc reported third quarter 2016 results. Diplomat Pharmacy Inc also lowered full year 2016 guidance, with the CEO and Chairman commenting, "We are disappointed with our third quarter results, which were significantly impacted by the softness in the hepatitis C business nationwide, as well as by DIR fees. The methodology and transparency around how PBMs are applying these DIR fees changed materially in 2016, and while we cannot reverse the impact they had on this quarter, we are working with our partners in the specialty pharmacy industry and with legislators to achieve an amicable solution to this problem." Shares of Diplomat Pharmacy Inc (NYSE:DPLO) declined to as low as $12.47 per share on November 4, 2016.
Those who purchased shares of Diplomat Pharmacy Inc (NYSE:DPLO) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Diplomat Pharmacy Inc (NYSE:DPLO) Investor News: Deadline in Lawsuit on January 9, 2016
A Deadline is coming up on January 9, 2016 in the lawsuit for investors in Diplomat Pharmacy Inc (NYSE:DPLO) and NYSE:DPLO stockholders should contact the Shareholders Foundation.